腹膜假黏液瘤7例临床分析(3)
 |
| 第1页 |
参见附件。
[14] Vaira M，Cioppa T，DE Marco G，et al. Management of pseudomyxoma peritonei by cytoreduction+HIPEC(hyperthermic intraperitoneal chemotherapy)：results analysis of a twelve-year experience [J]. In Vivo，2009，23(4)：639-644.
[15] Rampone B，Roviello F，Marrelli D，et al. Giant append iceal mucocele：report of a case and brief review [J]. World J Gastroenterol，2005，11(30)：4761-4763.
[16] Cole KL，Choudry HA，Jones HL，et al. Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with pseudomyxoma peritonei [J]. J Surg Oncol，2012，106(4)：513-516.
[17] Sorensen O，Flatmark K，Reed W，et al. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in pseudomyxoma peritonei [J]. Eur J Surg Oncol，2012，38(10)：969-976.
[18] 施素华，张正荣，李硕，等.腹膜假性粘液瘤7例的诊治体会[J].皖南医学院学报，2008，27(3)：212.
[19] 余燕武，余英清，江敏.腹膜假性粘液瘤的影像学分析[J].中国现代医生，2009，47(11)：140-141，118.
[20] Pillai K，Akhter J，Chua TC，et al. Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei [J]. Invest New Drugs，2012，30(5)：2080-2086.
[21] Pillai K，Akhter J，Chua TC，et al. Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei [J]. J Surg Res，2012，174(2)：69-73.
[22] Choudry HA，Mavanur A，O'Malley ME，et al. Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei [J]. Ann Surg Oncol，2012，19(5)：1402-1409.
[23] Chua TC，Liauw W，Morris DL. Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome [J]. Int J Colorectal Dis，2012，27(3)：381-389.
(收稿日期：2012-11-05 本文编辑：张瑜杰)
您现在查看是摘要介绍页，详见PDF附件(3094kb)。